Neuraxis, INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY September 30, 2023 | FY December 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $3.6M | $2.7M | $2.5M | — | $2.7M |
| Gross profit | $3.0M | $2.3M | $2.2M | — | $2.4M |
| Operating income | -$7.8M | -$7.2M | -$6.7M | — | -$3.4M |
| Cost of revenue | $562,916 | $362,002 | $303,345 | — | $297,060 |
| Cash from operations | -$6.4M | -$6.1M | -$6.7M | — | -$2.3M |
| Capital expenditure | $31,150 | $27,776 | $30,781 | — | $1,390 |
| Free cash flow | -$6.5M | -$6.1M | -$6.7M | — | -$2.3M |
| Impairments | $0 | $0 | — | — | — |
| Total assets | $6.4M | $4.8M | $509,498 | $1.2M | $1.5M |
| Total liabilities | $3.0M | $2.7M | $1.9M | $2.3M | $7.1M |
Shares outstanding 12.4M · Free float 51.7%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.